Details for Patent: 11,963,952
✉ Email this page to a colleague
Which drugs does patent 11,963,952 protect, and when does it expire?
Patent 11,963,952 protects ERLEADA and is included in one NDA.
This patent has thirteen patent family members in thirteen countries.
Drugs Protected by US Patent 11,963,952
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-001 | Feb 14, 2018 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF METASTATIC CASTRATION SENSITIVE PROSTATE CANCER | ⤷ Subscribe | ||||
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF METASTATIC CASTRATION SENSITIVE PROSTATE CANCER | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,963,952
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020215176 | ⤷ Subscribe | |||
| Brazil | 112021014969 | ⤷ Subscribe | |||
| Canada | 3128331 | ⤷ Subscribe | |||
| China | 113365623 | ⤷ Subscribe | |||
| Eurasian Patent Organization | 202192097 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
